<strong>Background: </strong>Numerous studies have demonstrated increasing evidence for cataractogenesis at lower levels of ionizing radiation than previously believed, with some suggesting possible absenc...<strong>Background: </strong>Numerous studies have demonstrated increasing evidence for cataractogenesis at lower levels of ionizing radiation than previously believed, with some suggesting possible absence of a threshold. Genetic differences between individuals also result in increased susceptibility in some operators, who might not be aware. European occupational exposure limits have been reduced and operators are seeking protective measures. <strong>Objective: </strong>To evaluate the protective effect of a face-shield equipped suspended protection system (Zero-Gravity<span style="white-space:nowrap;"><sup><span style="white-space:nowrap;">®</span></sup></span>, TIDI Products, Neenah, WI) along with adherence to safety practices against radiation dose to the eye lens for an interventional radiologist performing a wide variety of procedures. <strong>Materials and Methods:</strong> In this institutional review board-approved single-institution study, one interventional radiologist wore a highly sensitive personnel monitoring dosimeter badge on the cap near the left eye while performing 299 procedures (3690 fluoroscopy minutes) over 18 consecutive months while utilizing the suspended protection system along with adherence to other generally recommended safety practices and movement away from the field during angiographic power injections. Dosimetry reports and procedural information were retrospectively reviewed. <strong>Results: </strong>Total lens dose equivalent to the left eye over 18 months was 0.11 mSv (annualized dose = 0.073 mSv, or 7.3 mRem). The patient-dose-area product standardized dose of 0.00576 <span style="white-space:nowrap;"><span style="white-space:nowrap;"><span style="white-space:nowrap;">μ</span></span></span>Sv/Gy<span style="white-space:nowrap;"><span style="white-space:nowrap;">⋅</span></span>cm<sup>2</sup> is well below reports of conventional lead aprons, shields, and protective eyewear. <strong>Conclusion: </strong>Eye exposures were kept to near-background levels using the展开更多
由美国食品药品监督管理局(Food and Drug Administration,文中简称FDA)制定的监督管理法规具有很高的水平,堪称是世界上最为完善的管理制度,在国际上赢得了极高的声望和广泛的认可。本文系统介绍了美国FDA对电子产品辐射的控制监管体系...由美国食品药品监督管理局(Food and Drug Administration,文中简称FDA)制定的监督管理法规具有很高的水平,堪称是世界上最为完善的管理制度,在国际上赢得了极高的声望和广泛的认可。本文系统介绍了美国FDA对电子产品辐射的控制监管体系,供业内相关人员学习和参考。展开更多
文摘<strong>Background: </strong>Numerous studies have demonstrated increasing evidence for cataractogenesis at lower levels of ionizing radiation than previously believed, with some suggesting possible absence of a threshold. Genetic differences between individuals also result in increased susceptibility in some operators, who might not be aware. European occupational exposure limits have been reduced and operators are seeking protective measures. <strong>Objective: </strong>To evaluate the protective effect of a face-shield equipped suspended protection system (Zero-Gravity<span style="white-space:nowrap;"><sup><span style="white-space:nowrap;">®</span></sup></span>, TIDI Products, Neenah, WI) along with adherence to safety practices against radiation dose to the eye lens for an interventional radiologist performing a wide variety of procedures. <strong>Materials and Methods:</strong> In this institutional review board-approved single-institution study, one interventional radiologist wore a highly sensitive personnel monitoring dosimeter badge on the cap near the left eye while performing 299 procedures (3690 fluoroscopy minutes) over 18 consecutive months while utilizing the suspended protection system along with adherence to other generally recommended safety practices and movement away from the field during angiographic power injections. Dosimetry reports and procedural information were retrospectively reviewed. <strong>Results: </strong>Total lens dose equivalent to the left eye over 18 months was 0.11 mSv (annualized dose = 0.073 mSv, or 7.3 mRem). The patient-dose-area product standardized dose of 0.00576 <span style="white-space:nowrap;"><span style="white-space:nowrap;"><span style="white-space:nowrap;">μ</span></span></span>Sv/Gy<span style="white-space:nowrap;"><span style="white-space:nowrap;">⋅</span></span>cm<sup>2</sup> is well below reports of conventional lead aprons, shields, and protective eyewear. <strong>Conclusion: </strong>Eye exposures were kept to near-background levels using the
